VNUTRIVENNYE PREPARATY ZhELEZA V LEChENII ZhELEZODEFITsITNOY ANEMII
- Autores: Moiseev S.V1
-
Afiliações:
- Edição: Nº 20 (2015)
- Páginas: 78-82
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/288412
- ID: 288412
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Indications for intravenous administration of iron preparations for the treatment of iron deficiency anemia (IDA) include inefficiency or poor tolerance of oral iron therapy, severe anemia, IDA in the preoperative period, IDA against the background of inflammatory bowel disease associated with impaired absorption; there are also recommendations of combination therapy with erythropoiesis stimulating agents. A number of clinical studies have analyzed the results of intravenous administration of iron preparations in different regimens for the treatment of IDA.
Palavras-chave
Texto integral
Bibliografia
- Worldwide prevalence of anaemia 1993-2005. WHO global database of anaemia. Edited by de B. Benoist, et al. World Health Organisation. 2008.
- Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva, World Health Organization, 2001 (WH0/NHD/01.3).
- Авдеев В.Г., Моисеев С.В. Анемия при болезни Крона. Клин фармакол тер. 2013; 22(1): 10-5.
- Goodnough L.T. Iron deficiency syndromes and iron-restricted erythropoiesis. Transfusion (Paris) 2012; 52(7): 1584-92.
- Coyne D. Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int., 2011; 80(3): 240-44.
- Милованов Ю.С., Милованова Л.Ю., Козловская Л.В. Нефрогенная анемия: патогенез, прогностическое значение, принципы лечения. Клин. нефрол. 2010; 6: 7-18.
- Серов В.Н., Дубровина Н.В., Балушкина А.А. Железодефицитная анемия в гинекологической практике: основные принципы лечения. РМЖ, Мать и дитя. Акушерство и гинекология. 2011; 1: 1-4.
- Виноградова М.А. Карбоксимальтозат железа в лечении анемии в акушерско-гинекологической практике. Клин. фармакол. тер. 2014; 23(4): 36-40.
- Серов В.Н. Анемия при беременности. Клин. фармакол. тер. 2005; 14(2): 78-83.
- Моисеев С.В. Железа карбоксимальтозат (Феринжект) - новый внутривенный препарат для лечения железодефицитной анемии. Клин. Фармакол. тер. 2012; 21(2): 48-53.
- Hussain I., Bhoyroo J., Butcher A., Koch T.A., He A., Bregman D.B. Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia. Anemia. 2013; 2013: 169107.
- Рогачевский О.В., Моисеев С.В. Клиническое значение и лечение анемии в предоперационном периоде. Клин. Фармакол. тер. 2014; 23(2): 55-60.
- Musallam K.M., Tamim H.M., Richards T., Spahn D.R., Rosendaal F.R., Habbal A., Khreiss M., Dahdaleh F.S., Khavandi K., Sfeir P.M., Soweid A., Hoballah J.J., Taher A.T., Jamali F.R. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011; 378: 1396-407.
- Lin D.M., Lin E.S., Tran M.H. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus. Med. Rev. 2013; 27(4): 221-34.
- Auerbach M., Ballard H., Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007; 369: 1502-4.
- Hedenus M., Birgegxrd G. The role of iron supplementation during epoietin treatment for cancer-related anemia. Med. Oncol. 2009; 26(1): 105-15.
- Crichton R., Danielson B., Geisser P. Iron therapy with special emphasis on intravenous administration. 4th edition. London, Boston: International Medical Publishers. 2008.
- Favrat B., Balck K., Breymann C., Hedenus M., Keller T., Mezzacasa A., Gasche C. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women - PREFER a randomized, placebo-controlled study. PLoS One. 2014; 9(4): e94217.
- Koch T.A., Myers J., Goodnough L.T. Intravenous iron therapy in patients with iron deficiency anemia: sosing considerations. Anemia. 2015; http://dx.doi.org/10.1155/2015/763576.
- Van Wyck D.B., Martens M.G., Seid M., Baker J.B., Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstetrics Gynecol. 2007; 110(2): 267-78.
- Van Wyck D.B., Mangione A., Morrison J., Hadley P.E., Jehle J.A., Goodnough L.T. Largedose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009; 49(12): 2719-28.
- Seid M.H., Derman R.J., Baker J.B., Banach W., Goldberg C., Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am. J. Obstet. Gynecol. 2008; 199(4): 435. e1-7.
- Barish C.F., Koch T., Butcher A., Morris D., Bregman D.B. Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials. Anemia. 2012; 2012: 172104.
- Onken J.E., Bregman D.B., Harrington R.A., Morris D., Acs P., Akright B., Barish C., Bhaskar B.S., Smith-Nguyen G.N., Butcher A., Koch T.A., Goodnough L.T. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 2014; 54(2): 306-15.
- Onken J.E., Bregman D.B., Harrington R.A., Morris D., Buerkert J., Hamerski D., Iftikhar H., Mangoo-Karim R., Martin E.R., Martinez C.O., Newman G.E., Qunibi W.Y., Ross D.L., Singh B., Smith M.T., Butcher A., Koch T.A., Goodnough L.T. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrology. 2014; 29(4): 833-42.
- Horl W.H., Vanrenterghem Y., Aljama P., et al. OPTA-therapy with iron and erythropoiesis-stimulating agents in chronic kidney disease. Nephrology Dialysis Transplantation. 2007; 22(Suppl. 3): 2-6.
Arquivos suplementares
